Medtronic AneuRx Stent Graft System
Audience: Vascular surgery healthcare professionals, hospital surgical service managers
[Posted 03/18/2008] FDA issued a Public Health Notification to inform healthcare professionals of an update to earlier FDA safety information on this product. The notification re-emphasizes the need for continued surveillance of patients treated with endovascular grafts, and provides updated information on the mortality risks associated with the use of the AneuRx Stent Graft System to prevent abdominal aortic aneurysm rupture.
[March 17, 2008 - Public Health Notification - FDA]